Kevin Kotler’s Broadfin Capital Initiates Stake in Eleven Biotherapeutics (EBIO) Following Its IPO

Broadfin Capital, led by Kevin Kotler, in a filing with the Securities and Exchange Commission, reported initiating a position in Eleven Biotherapeutics, Inc. (NASDAQ:EBIO). The fund currently owns 896,100 shares, which is equivalent to 5.55% of the common stock of the company.

Kevin Kotler

Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) is a Massachusetts based company, focused on discovering and developing protein therapeutics to treat ocular diseases. The stock of the company began trading on the NASDAQ Global Market a couple of weeks ago. The company raised $50.0 million in an initial public offering of 5.00 million shares of its common stock at a price of $10.00 per share.

At the end of the fourth quarter of 2013, total value of the equity portfolio of Broadfin Capital was $1.45 billion. Kevin Kotler’s Broadfin Capital had the largest investment in Aerie Pharmaceuticals Inc (NASDAQ:AERI), the position amassing 391,232 shares, worth $702.65 million. The next big holding in its equity portfolio is the specialty pharmaceutical company, Depomed Inc (NASDAQ:DEPO), in which the fund reported 4.74 million shares, with a value of $50.2 million. Another significant investment of the fund is in Lannett Company, Inc. (NASDAQ:LCI) with a reported stake of 1.34 million shares, worth $44.35 million.

Early this year, the fund revealed a new stake in Retrophin Inc (NASDAQ: RTRX). Broadfin Capital now owns 1.61 million shares in this biotechnology company, which is equivalent to 6.93% of the common stock of Retrophin Inc (NASADQ:RTRX).

Late last year, Kevin Kotler’s Broadfin Capital upped its position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to 4.5 million shares from around 3.6 million shares held earlier. Around the same period, the fund also increased its position in Derma Sciences Inc (NASDAQ:DSCI) to 871,600 shares from 771, 600 shares held earlier.

Disclosure: none

Recommended Reading:

Edward Gilhuly and Sageview Capital’s New Stock Moves

Lance Helfert and Paul Orfalea’s Top Holdings and Latest Sales

New Picks of Steve Cohen’s SAC Capital Advisors

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

10 Worst Airlines in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!